Abstract:Objective To explore the differential expressions of ovarian cancer stem cells (OCSC) markers CD133 and CD44 in primary and recurrent epithelial ovarian cancer (EOC) tissues and its significances.Methods From January 1,2003 to December 31,2016,a total of 15 patients with recurrent EOC,30 primary EOC patients with advanced stage who did not receive chemotherapy before surgery,and 30 primary EOC patients with advanced stage who received neoadjuvant chemotherapy (NACT) before surgery in West China Second University Hospital,Sichuan University were selected as research subjects,and they were included into the recurrent group (n=15),non-chemotherapy group (n =30),and NACT group (n=30).The positive expression rates and optical density (OD) of CD133 and CD44 in different types of EOC tissues were detected by immuohistochemistry.Paired chi-square test and Wilcoxon signed rank sum test were used to compare the positive expression rates and OD of CD133 and CD44 between EOC tissues of primary and recurrent surgery in recurrent group.Chi-square test and Wilcoxon rank sum test were used to compare the positive expression rates and OD of CD133 and CD44 between EOC tissues of non-chemotherapy group and NACT group.Correlation analysis of CD44 and CD133 expressions in EOC tissues was analyzed by Cramer's V coefficient.This study met the requirements of the World Medical Association Declaration of Helsinki revised in 2013.There were no significant differences in the general clinical data of age,pathological type and grade between the three groups (P＞0.05).Results ①In recurrent group,there were no statistical differences between EOC tissues of primary and recurrent surgery in positive expression rates of CD133,and OD of CD133 and CD44 (P＞0.05).The positive expression rate of CD44 in EOC tissues of recurrent surgery was 86.7％ (13/15),which was higher than that in primary surgery [73.3％ (11/15)],and the difference was statistically significant (x2 =4.922,P=0.027).②The OD of CD133 and CD44,and the positive expression rate of CD44 in EOC tissues of NACT group all were higher than those of non-chemotherapy group,and all the differences were statistically significant (Z=-2.176,P=0.030;x2 =5.455,P=0.020;Z=-4.759,P＜0.001).③There was correlation between the expressions of CD133 and CD44 in EOC tissues (Cramer's V=0.462,P＜0.001).Conclusions The OCSC markers CD133 and CD44 are co-expressed in EOC tissues and may co-exist on the surface of OCSC.The residue of OCSC after chemotherapy may be the real cause of EOC recurrence.

Expression of CD44 and NANOG in epithelial ovarian cancer and its clin-ical significance

Nanog is highly expressed in ovarian serous cystadenocarcinoma and correlated with clinical stage and pathological grade.

CDK1 as a Novel Potential Biomarker for Predicting the Prognosis of endometrioid ovarian carcinoma

High Expression of ENPP1 in High-Grade Serous Ovarian Carcinoma Predicts Poor Prognosis and As a Molecular Therapy Target.

Overexpression of CD 44 and EpCAM may be associated with the initiation and progression of epithelial ovarian cancer

Expressions of CD133 and CD44 in Primary and Recurrent Epithelial Ovarian Cancer Tissues

[Clinical Significance of CD44 Expression in Ovarian Epithelial Tumors].

CD44 Expression Predicts Prognosis of Ovarian Cancer Patients Through Promoting Epithelial-Mesenchymal Transition (EMT) by Regulating Snail, ZEB1, and Caveolin-1

Clinical Significance and Prognostic Value of Extracellular Signal-Regulated Kinases in Epithelial Ovarian Cancer

Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer

Expression of CD44V6,VEGF and nm23-H1 on Ovarian Cancerous Tissue and Its Clinical Significance

Expressions of OCT4, Notch1 and DLL4 and Their Clinical Implications in Epithelial Ovarian Cancer

Stem Cell Transcription Factor NANOG Controls Cell Migration and Invasion Via Dysregulation of E-cadherin and FoxJ1 and Contributes to Adverse Clinical Outcome in Ovarian Cancers.

Expression of OCT4,SOX2 and Nanog and its significance in cervical cancer

Expressions of IGF1,IGF1R,IGFBP3 and their relationship with biological behavior of epithelial ovarian cancer

Expression and Significance of C-erbB2,CD44v5 in Human Ovarian Cancer

Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies.

Co-expression of CD44/MyD88 is a Poor Prognostic Factor in Advanced Epithelial Ovarian Cancer

Expression of Nucleostemin Gene in Epithelial Ovarian Tumor and Its Relation with Clinical Pathology

Expression and clinical significance of EGFR in ovarian cancer

Gli affects the stemness and prognosis of epithelial ovarian cancer via homeobox protein NANOG